It has been shown that tumors have developed numerous ways to escape tumor specific immune responses. These mechanisms will ultimately not only enhance tumor growth, but also impair the effect of immune based therapies in cancer. Myeloid derived suppressor cells represent a recently identified cell population, which has been shown to impair tumor specific immune responses both in mice and human. We have been able to identify a human counterpart of the initially only in mice described MDSC, which is characterized by the expression of CD14 and low/no levels of HLA-DR. In the past year we have been able to demonstrate that while CD14+HLA-Dr low/neg cells induce MDSC in vitro, CD14+HLA-DR+ cells actually induce Th17 cells. Interestingly we have also been able to demonstrate in increase in the frequency of Th17 cells in HCC patients. Our data suggest that Th17 cell suppress T cells responses through a TGF-beta mediated mechanism. Finally we have been able to characterize human MDSC in more detail and identified a new marker (S100), which is specific for human MDSCs.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
National Cancer Institute Division of Basic Sciences
Zip Code
Duffy, Austin G; Ulahannan, Susanna V; Makorova-Rusher, Oxana et al. (2017) Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma. J Hepatol 66:545-551
Duffy, A G; Greten, T F (2014) Immunological off-target effects of standard treatments in gastrointestinal cancers. Ann Oncol 25:24-32
Duffy, Austin; Zhao, Fei; Haile, Lydia et al. (2013) Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies. Cancer Immunol Immunother 62:299-307
Greten, Tim F; Zhao, Fei; Gamrekelashvili, Jaba et al. (2012) Human Th17 cells in patients with cancer: Friends or foe? Oncoimmunology 1:1438-1439
Zhao, Fei; Hoechst, Bastian; Gamrekelashvili, Jaba et al. (2012) Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responses. J Immunol 188:6055-62
Zhao, Fei; Korangy, Firouzeh; Greten, Tim F (2012) Cellular immune suppressor mechanisms in patients with hepatocellular carcinoma. Dig Dis 30:477-82
Zhao, Fei; Hoechst, Bastian; Duffy, Austin et al. (2012) S100A9 a new marker for monocytic human myeloid-derived suppressor cells. Immunology 136:176-83
Greten, Tim F; Manns, Michael P; Korangy, Firouzeh (2011) Myeloid derived suppressor cells in human diseases. Int Immunopharmacol 11:802-7
Hoechst, Bastian; Gamrekelashvili, Jaba; Manns, Michael P et al. (2011) Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. Blood 117:6532-41